Literature DB >> 7609081

Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein.

K H Siebelink1, W Huisman, J A Karlas, G F Rimmelzwaan, M L Bosch, A D Osterhaus.   

Abstract

Sites involved in antibody-mediated neutralization of feline immunodeficiency virus were mapped by reciprocal exchange of envelope fragments or amino acids between molecular clones of feline immunodeficiency virus with different susceptibilities to neutralization by a polyclonal cat serum. Combinations of mutations within HV-4 or within HV-4 and HV-5 changed the susceptibility of the viruses to neutralizing antibody.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7609081      PMCID： PMC189331          DOI： 10.1128/JVI.69.8.5124-5127.1995

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  28 in total

1.  Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.

Authors:  N L Haigwood; P L Nara; E Brooks; G A Van Nest; G Ott; K W Higgins; N Dunlop; C J Scandella; J W Eichberg; K S Steimer
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Hematologic manifestations of feline immunodeficiency virus infection.

Authors:  G H Shelton; M L Linenberger; C K Grant; J L Abkowitz
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

3.  Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections.

Authors:  J E Barlough; C D Ackley; J W George; N Levy; R Acevedo; P F Moore; B A Rideout; M D Cooper; N C Pedersen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

4.  Feline immunodeficiency virus: a neurotropic lentivirus.

Authors:  S W Dow; M L Poss; E A Hoover
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1.

Authors:  D Davis; D M Stephens; C Willers; P J Lachmann
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

6.  Two different mutations in the envelope protein of feline immunodeficiency virus allow the virus to escape from neutralization by feline serum antibodies.

Authors:  K H Siebelink; M L Bosch; G F Rimmelzwaan; R H Meloen; A D Osterhaus
Journal:  Vet Immunol Immunopathol       Date:  1995-05       Impact factor: 2.046

7.  Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens.

Authors:  S Alexander; J H Elder
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

8.  Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat.

Authors:  K H Siebelink; I H Chu; G F Rimmelzwaan; K Weijer; A D Osterhaus; M L Bosch
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.

Authors:  C D Ackley; J K Yamamoto; N Levy; N C Pedersen; M D Cooper
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

10.  Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function.

Authors:  K H Siebelink; I H Chu; G F Rimmelzwaan; K Weijer; R van Herwijnen; P Knell; H F Egberink; M L Bosch; A D Osterhaus
Journal:  AIDS Res Hum Retroviruses       Date:  1990-12       Impact factor: 2.205
View more
  14 in total

1.  During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.

Authors:  M Bendinelli; M Pistello; D Del Mauro; G Cammarota; F Maggi; A Leonildi; S Giannecchini; C Bergamini; D Matteucci
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  Feline immunodeficiency virus model for designing HIV/AIDS vaccines.

Authors:  Janet K Yamamoto; Missa P Sanou; Jeffrey R Abbott; James K Coleman
Journal:  Curr HIV Res       Date:  2010-01       Impact factor: 1.581

3.  Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection.

Authors:  Britta A Wood; Scott Carver; Ryan M Troyer; John H Elder; Sue VandeWoude
Journal:  J Immunol Methods       Date:  2013-08-14       Impact factor: 2.303

4.  Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates.

Authors:  D Del Mauro; D Matteucci; S Giannecchini; F Maggi; M Pistello; M Bendinelli
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Variability and immunogenicity of caprine arthritis-encephalitis virus surface glycoprotein.

Authors:  S Valas; C Benoit; C Baudry; G Perrin; R Z Mamoun
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype.

Authors:  R Skraban; S Matthíasdóttir; S Torsteinsdóttir; G Agnarsdóttir; B Gudmundsson; G Georgsson; R H Meloen; O S Andrésson; K A Staskus; H Thormar; V Andrésdóttir
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence.

Authors:  Margaret J Hosie; Brian J Willett; Dieter Klein; Thomas H Dunsford; Celia Cannon; Masayuki Shimojima; James C Neil; Oswald Jarrett
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

Authors:  Brian J Willett; Martin Kraase; Nicola Logan; Elizabeth L McMonagle; Ayman Samman; Margaret J Hosie
Journal:  Retrovirology       Date:  2010-04-26       Impact factor: 4.602

9.  Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C.

Authors:  Sohela de Rozières; Candace K Mathiason; Matthew R Rolston; Udayan Chatterji; Edward A Hoover; John H Elder
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Role of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus.

Authors:  Simone Giannecchini; Mauro Pistello; Patrizia Isola; Donatella Matteucci; Paola Mazzetti; Giulia Freer; Mauro Bendinelli
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.